Early-life pulmonary immunity and development of paediatric inflammatory respiratory diseases

C. Lloyd (London, United Kingdom)

Source: International Congress 2019 – Early origins of lung disease: an interdisciplinary approach
Session: Early origins of lung disease: an interdisciplinary approach
Session type: Symposium
Number: 444
Disease area: Paediatric lung diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Lloyd (London, United Kingdom). Early-life pulmonary immunity and development of paediatric inflammatory respiratory diseases. International Congress 2019 – Early origins of lung disease: an interdisciplinary approach

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Early-life origin of airway diseases
Source: International Congress 2019 – State of the art session: Airway disease
Year: 2019


Impact of viruses on airway diseases
Source: Eur Respir Rev 2005; 14: 57-61
Year: 2005



Revisiting the role of pulmonary surfactant in chronic inflammatory lung diseases and environmental exposure
Source: Eur Respir Rev, 30 (162) 210077; 10.1183/16000617.0077-2021
Year: 2021



Relevance of innate immune responses to chronic airway diseases
Source: Annual Congress 2008 - The battle between environmental “invaders” and airway epithelial defences
Year: 2008


Interplay between bacterial infections, hypoxia and the development of chronic lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009


The role of chronic infection in respiratory diseases
Source: International Congress 2018 – Chinese Programme 2018: Part I
Year: 2018


The adaptive immune system, autoimmunity and COPD: lessons from human studies
Source: Annual Congress 2007 - T- and B-cells in COPD: a role for adaptive immunity in the pathogenesis of COPD?
Year: 2007


The role of pulmonary rehabilitation in the prevention of exacerbations of chronic lung diseases
Source: Eur Respir Monogr 2017; 77: 224-246
Year: 2017


The microbiome in chronic respiratory diseases
Source: International Congress 2017 – Can we translate the microbiome from basic science to clinical practice?
Year: 2017


Severe pulmonary infections due to biological therapy of rheumatic diseases
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011


Early childhood respiratory infections do not protect against asthma and atopic disease
Source: ISSN=ISSN 1810-6838, ISBN=, page=261
Year: 2006

Impact of bacterial infections on airway diseases
Source: Eur Respir Rev 2005; 14: 62-68
Year: 2005



Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009

The microbiome and childhood respiratory diseases
Source: International Congress 2018 – Microbiomes in respiratory disease
Year: 2018


Cardiovascular implications of pulmonary hypertension due to chronic respiratory diseases
Source: Eur Respir Monogr 2020; 88: 167-183
Year: 2020


Immune system dysregulation in chronic lung disease
Source: Eur Respir J 2011; 38: 500-501
Year: 2011


Bacterial bronchopulmonary infection-induced exacerbation of chronic obstructive pulmonary diseases
Source: Eur Respir J 2002; 20: Suppl. 38, 258s
Year: 2002

Influence of innate immunity on respiratory disease development and vaccination process
Source: Eur Respir J 2006; 28: Suppl. 50, 341s
Year: 2006